ACE and myocardial infarction: A comprehensivemeta-analysis of large, randomized placebo-controlled trials including~100,000 patients highlighted beneficial effects ofangiotensin converting enzyme (ACE)-inhibitors on long-term survival with 85% of the effect within the firstseven days after myocardial infarction [7].